Onderneming Xbrane Biopharma AB Nasdaq Stockholm
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- SEK | - |
02/05 | Xbrane Biopharma AB (Publ) benoemt Kristoffer Bissessar tot nieuwe directeur | CI |
22/04 | Transcript : Xbrane Biopharma AB - Special Call |
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 58 | 100,0 % | 239 | 100,0 % | +314,33% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe
88,0
%
| 7 | 11,6 % | 210 | 88,0 % | +3.034,33% |
North America
12,0
%
| 51 | 88,4 % | 29 | 12,0 % | -43,61% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Martin Åmark
CEO | Chief Executive Officer | 44 | 01-01-15 |
Anette Lindqvist
DFI | Director of Finance/CFO | 63 | 11-01-21 |
Dina Jurman
CTO | Chief Tech/Sci/R&D Officer | 42 | 09-10-17 |
David Vikström
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-01-14 |
Siavash Bashiri
COO | Chief Operating Officer | 41 | 01-01-15 |
Nina Ivers
HRO | Human Resources Officer | 54 | 16-12-20 |
Xiaoli Hu
PRN | Corporate Officer/Principal | 42 | 01-05-20 |
Maria Edebrink
LAW | General Counsel | 55 | 01-01-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 67 | 01-01-15 | |
Director/Board Member | 70 | 01-01-15 | |
Director/Board Member | 53 | 01-01-20 | |
Eva Nilsagård
BRD | Director/Board Member | 60 | 16-05-19 |
Director/Board Member | - | 16-05-19 | |
Kirsti Gjellan
BRD | Director/Board Member | 61 | 05-05-22 |
Chairman | 63 | 03-04-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 520 328 564 | 1 357 063 187 ( 89,26 %) | 0 | 89,26 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |
- Beurs
- Aandelen
- Koers XBRANE
- Koers
- Onderneming Xbrane Biopharma AB